Immunotherapy for Recurrent Pregnancy Loss: Analysis of Results From Clinical Trials

199696 citationsReview

Authors

Carolyn B. Coulam · Genetics and IVF Institute

Mary D. Stephenson · University of British Columbia

J. Jaros Stern · Hospital Angeles Pedregal

Abstract

Chromosomal abnormalities are a significant confounder when evaluating efficacy of immunotherapy for treatment of RSA. Some women with RSA have a high risk of recurrent chromosomal problems.

Topics & Keywords

Reproductive System and Pregnancy Ectopic Pregnancy Diagnosis and Management Pregnancy and Medication Impact

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: American Journal of Reproductive Immunology

Volume 35, Issue 4, pp. 352-359

DOI: 10.1111/j.1600-0897.1996.tb00493.x

Field-Weighted Citation Impact: 1.71